Pharmaceuticals occupiers in Santiago typically cluster in Nueva Las Condes, plan ~220 sqft per seat at high-end fit-out ($500000–740000/sqft), and pay around 22000 CLP/sqft ($27 USD) on Class A.
Pharmaceuticals occupiers in Santiago typically cluster in Nueva Las Condes, plan ~220 sqft per seat at high-end fit-out">fit-out ($500000–740000/sqft), and pay around 22000 CLP/sqft ($27 USD) on Class A.
Pharmaceuticals occupiers in Santiago typically anchor in Nueva Las Condes. Multinational HQs, tech, telecom, professional services.
Class A rent in Santiago runs 22000 CLP/sqft ($27 USD) on a 5-year lease with 4 months free. Prime submarkets sit at or modestly above the city index.
Typical pharmaceuticals fit-out targets high-end specification at $500000–740000/sqft. Branded reception, full client-facing programming, premium furniture, and specialist AV are standard.
Plan around 220 sqft per seat blended (workstation + circulation + amenity). A 100-headcount pharma office in Santiago typically targets 22,000 sqft of leasable area.
Commercial and medical-affairs teams cluster near academic-medical anchors; large floor plates support cross-functional brand teams. Deep mining, banking, and retail talent. Strong feed from Pontificia Universidad Católica, Universidad de Chile, Universidad Adolfo Ibáñez. Spanish-English bilingual professional base.
Headline corporate tax: 27%. Net leases. 5-year terms with renewal options. Free rent of 3-6 months and TI of CLP 280,000-500,000/sqm typical. UF (Unidad de Fomento) inflation indexation common.
| city | Santiago |
|---|---|
| industry | Pharmaceuticals |
| naics | 3254, 5417 |
| preferredSubmarket | Nueva Las Condes |
| preferredFitoutSpec | High-end |
| fitoutBand | $500000–740000/sqft |
| sqftPerSeat | 220 |
| classARentLocal | 22000 CLP/sqft/yr |
| classARentUsd | $27/sqft/yr |
| vacancyPct | 9.4% |
| typicalLeaseYears | 5 |
| typicalRentFreeMonths | 4 |
| talentIndex | 80 |
| corporateTaxPct | 27% |
Reviewed by Miriam Hollander — Lead market analyst. Last updated 2026-04-15. See our methodology and editorial standards.